Surface Oncology, Inc(NASDAQ:SURF) 
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 (IgG4) monoclonal antibody for the production of extracellular a...
Website: http://www.surfaceoncology.com
Founded: 2014
Full Time Employees: 49
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-13
P
O 0.68
H 0.69
L 0.66
C 0.67
V 191,709
10EMA 0.67
20EMA 0.67
60EMA 0.67
120EMA 0.67
250EMA 0.67